Feasibility Study of Whole Egg Consumption in Adults With Intermediate Age-related Macular Degeneration
Kathryn Starr
Summary
Age-related macular degeneration (AMD) is the primary cause of vision loss in people over the age of 55. Currently, no cure is available for individuals suffering from AMD. The purpose of this pilot study is to evaluate the feasibility of implementing a 5-month egg intervention in adults with intermediate AMD. The objective of this research study is to evaluate the feasibility of a whole egg (2 or 4 per day) intervention in older adults with intermediate AMD. The secondary objective of this research is to determine descriptive statistics, change over time and estimate effect sizes for retinal sensitivity, and vision, cognition and physical function. By completing these research objectives, the researchers hope to gain preliminary evidence in support of a larger trial that will assess the impact of egg consumption on eye health in adults with AMD.
Eligibility
- Age range
- 55+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Diagnosed with intermediate dry AMD as noted in their medical record (defined as having multiple medium drusen, at least one large druse (\>125 μm or the approximate size of a vessel coming off the optic nerve), and/or non-center involving geographic atrophy) who are BCVA stable from prior exam within 6 months - defined by change of \< 10 letters on EDTRS chart (BCVA within 10 letters within past 6 months) * 55 years of age and older * Willing to limit consumption of eggs for one month prior to beginning the study intervention * Willing to follow diet protocol * Body Mas…
Interventions
- DrugWhole Egg - 4
Participants will be asked to consume 4 medium Eggland's Best eggs per day for 5 months.
- DrugWhole Egg - 2
Participants will be asked to consume 2 medium Eggland's Best eggs per day for 5 months.
Location
- Duke Center for LivingDurham, North Carolina